Solving Cost and Supply Challenges in Biopharma Downstream Processing

Published on: 

Sponsored Content

As the most expensive stage of monoclonal antibody production, downstream processing presents numerous opportunities to increase efficiency and raw material performance. This article discusses advances in purification process materials, as well as emerging technologies to aggregate and analyze data, as possible solutions to these challenges.